Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)
Journal article published in 2023 by
Alexandra Griessbach,
Frederique Chammartin 
,
Irene A. Abela,
Patrizia Amico,
Huldrych F. Günthard,
Marcel P. Stoeckle,
Anna L. Eichenberger,
Barbara Hasse,
Thomas F. Müller,
Dominique L. Braun,
Mace M. Schuurmans,
Thomas F. Mueller,
Karoline Aebi-Popp,
Michael Tamm,
Alexia Anagnostopoulos
and other authors.
,
Irene A. Abela,
Patrizia Amico,
Huldrych F. Günthard,
Marcel P. Stoeckle,
Anna L. Eichenberger,
Barbara Hasse,
Thomas F. Müller,
Dominique L. Braun,
Mace M. Schuurmans,
Thomas F. Mueller,
Karoline Aebi-Popp,
Michael Tamm,
Alexia Anagnostopoulos
and other authors.
